Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide is a synthetic peptide that mimics a gut hormone called GLP-1, reducing appetite and slowing how quickly your stomach empties. Licensed in the UK for weight management under the brand name Wegovy, it requires a prescription following a clinical assessment — a prescriber decides whether it is suitable for you, based on your full health picture. If you have spent time reading about this treatment and still feel unsure what it actually does to your body day-to-day, or what you should be eating while you take it, this page works through both questions steadily. Wegovy's treatment overview has the broader eligibility and dosing context if you need it alongside this.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
GLP-1 stands for glucagon-like peptide-1. Your gut releases it naturally after a meal; it signals to the brain that you have eaten, slows gastric emptying, and prompts the pancreas to release insulin in response to food. Semaglutide is a synthetic version of this peptide, engineered to be more stable so it lasts in the body far longer than the natural hormone.
What this produces, in practice, is a quietening of food noise, the near-constant background pull towards eating that many people on treatment describe as something they had always assumed was just how hunger felt. Portions that would previously have felt inadequate start to feel sufficient. The urge to snack between meals often diminishes without deliberate effort.
That quietening is also why food quality becomes more important, not less. When appetite is reduced, every meal carries more nutritional weight. If the small amount you eat is largely ultra-processed or low in protein, you can lose muscle alongside fat, feel fatigued, and find the gastrointestinal side effects (nausea, loose stools, constipation) harder to manage. The NHS's semaglutide patient information lists these GI effects as the most common early on, typically settling as your body adjusts to each dose step.
The practical implication: think of the peptide as doing its job on appetite, and your diet as doing its job on nutrition. Both matter.
Starting dose weeks tend to be when nausea is most noticeable. Smaller, more frequent meals often help. Cold or room-temperature food can sit better than hot dishes for some people. Bland, easily digested options (plain rice, boiled potatoes, eggs, plain yoghurt) give calories without overwhelming a sensitive stomach. Spicy food and very high-fat meals tend to worsen nausea during the early titration phase, so most people find it easier to ease back on those temporarily.
Once your system has settled at a given dose, the priority shifts to hitting adequate protein. Clinical guidance and dietitian consensus consistently point to protein as the nutrient most at risk when eating volumes fall: it protects muscle mass, keeps you fuller for longer, and supports tissue repair. Practical sources that tend to work well on treatment include eggs, white fish, chicken, Greek yoghurt, cottage cheese, legumes and tofu. Aiming for protein at every meal (even a small one) is a sensible habit.
Fibre matters too. Constipation is a common complaint as gastric emptying slows. Vegetables, oats, pulses and fruit (with the skin on, where edible) all help. Drinking enough plain water throughout the day is equally important, dehydration compounds constipation and can make nausea worse. The specific food guidance for Wegovy on this site covers these principles in more detail, including practical meal ideas.
Alcohol reduces gradually for many people on treatment simply because appetite for it drops alongside food appetite, but it is worth being aware that alcohol can lower blood sugar and contributes empty calories. Moderation remains sensible.
Semaglutide is not a short course. The STEP 1 trial (a 68-week study published in the New England Journal of Medicine) found that participants taking 2.4mg weekly lost on average around 15% of body weight over the trial period alongside lifestyle changes. That kind of result takes months, not weeks, and the dietary habits built during treatment turn out to matter a great deal after it too.
When treatment eventually ends, appetite typically returns over weeks to months. Weight regain is common if no sustainable eating pattern has been established during treatment, a reality worth being honest about from the start. What happens to appetite after stopping semaglutide is addressed in a separate page for anyone planning ahead.
NICE's appraisal of semaglutide for weight management notes that treatment under NHS criteria is recommended for a maximum of two years; private treatment timelines are agreed between the patient and their prescriber based on progress and clinical suitability. How long Wegovy treatment typically lasts covers this in more depth. The dietary principles above are relevant throughout, they are not a phase-one addition to be dropped once the medicine feels familiar.
It is worth saying plainly: if you are at the stage of researching all of this carefully before starting, that instinct is a good one. People who go into treatment with realistic expectations and a practical food plan tend to find the process more manageable. That is something our prescribers hear regularly from patients who feel they wish they had prepared more deliberately. Wegovy for weight loss gives a fuller picture of what the treatment programme involves, and what the cost of Wegovy includes is set out clearly on the pricing page if that is the next question on your list.
Semaglutide as a prescription treatment is subject to clinical assessment at each stage. If you would like to explore whether it is suitable for you, speaking to our prescribers through a free consultation is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.